17,359 Shares in Versigent $VGNT Acquired by Virtus Advisers LLC

Virtus Advisers LLC bought a new position in shares of Versigent (NYSE:VGNT) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 17,359 shares of the company’s stock, valued at approximately $780,000.

Several other large investors also recently bought and sold shares of VGNT. Fortitude Family Office LLC increased its stake in Versigent by 497.1% during the 3rd quarter. Fortitude Family Office LLC now owns 621 shares of the company’s stock valued at $28,000 after purchasing an additional 517 shares in the last quarter. Salomon & Ludwin LLC raised its holdings in shares of Versigent by 78.3% in the third quarter. Salomon & Ludwin LLC now owns 708 shares of the company’s stock worth $32,000 after buying an additional 311 shares during the last quarter. Jacobi Capital Management LLC purchased a new position in shares of Versigent in the third quarter worth $38,000. Farther Finance Advisors LLC lifted its stake in shares of Versigent by 53.1% during the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock worth $47,000 after buying an additional 365 shares during the period. Finally, Signaturefd LLC lifted its stake in shares of Versigent by 40.0% during the third quarter. Signaturefd LLC now owns 1,121 shares of the company’s stock worth $50,000 after buying an additional 320 shares during the period.

Versigent Stock Performance

NYSE VGNT traded down $0.34 during trading hours on Friday, reaching $42.12. The stock had a trading volume of 449,859 shares, compared to its average volume of 865,765. The stock has a fifty day moving average of $44.26 and a 200 day moving average of $42.67. The stock has a market cap of $2.98 billion and a P/E ratio of 11.00. Versigent has a 52-week low of $26.34 and a 52-week high of $50.88. The company has a debt-to-equity ratio of 5.69, a quick ratio of 1.11 and a current ratio of 1.43.

Versigent (NYSE:VGNT) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $1.91 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.12. Versigent had a net margin of 5.47% and a return on equity of 88.25%. The company had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.42 billion. Sell-side analysts predict that Versigent will post 7.37 earnings per share for the current year.

Versigent Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Friday, December 4th will be paid a dividend of $0.13 per share. This represents a $0.52 annualized dividend and a yield of 1.2%. The ex-dividend date is Friday, December 4th.

Insider Activity at Versigent

In other news, Director Kevin Clark sold 47,761 shares of the company’s stock in a transaction on Thursday, October 8th. The shares were sold at an average price of $44.36, for a total value of $2,118,677.96. Following the sale, the director directly owned 27,571 shares of the company’s stock, valued at $1,223,049.56. This represents a 63.40% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Over the last quarter, insiders have sold 220,000 shares of company stock valued at $10,065,848.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Fox Advisors lowered shares of Versigent from an “overweight” rating to an “equal weight” rating in a report on Wednesday, August 5th. Wells Fargo & Company upped their target price on Versigent from $48.00 to $56.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. TD Cowen raised their target price on Versigent from $58.00 to $59.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Weiss Ratings lowered Versigent from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, November 9th. Finally, Oppenheimer set a $50.00 price target on Versigent in a research report on Tuesday, July 21st. Eleven research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $55.08.

Versigent Company Profile

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.